Cubist Systematic Strategies’s Exelixis EXEL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-264,642
| Closed | -$6.87M | – | 3143 |
|
|
2024
Q3 | $6.87M | Buy |
+264,642
| New | +$6.58M | 0.04% | 652 |
|
|
2024
Q2 | – | Sell |
-253,289
| Closed | -$6.01M | – | 3290 |
|
|
2024
Q1 | $6.01M | Sell |
253,289
-280,290
| -53% | -$6.23M | 0.03% | 852 |
|
|
2023
Q4 | $12.8M | Sell |
533,579
-487,620
| -48% | -$10.6M | 0.08% | 324 |
|
|
2023
Q3 | $22.3M | Buy |
1,021,199
+553,697
| +118% | +$11.6M | 0.16% | 104 |
|
|
2023
Q2 | $8.93M | Sell |
467,502
-75,936
| -14% | -$1.46M | 0.06% | 491 |
|
|
2023
Q1 | $10.5M | Buy |
543,438
+487,786
| +876% | +$8.5M | 0.06% | 431 |
|
|
2022
Q4 | $893K | Sell |
55,652
-213,013
| -79% | -$3.47M | 0.01% | 2562 |
|
|
2022
Q3 | $4.21M | Sell |
268,665
-102,157
| -28% | -$1.97M | 0.02% | 1241 |
|
|
2022
Q2 | $7.72M | Buy |
370,822
+42,029
| +13% | +$866K | 0.05% | 632 |
|
|
2022
Q1 | $7.45M | Buy |
328,793
+181,602
| +123% | +$3.55M | 0.06% | 456 |
|
|
2021
Q4 | $2.69M | Sell |
147,191
-76,844
| -34% | -$1.47M | 0.03% | 1116 |
|
|
2021
Q3 | $4.74M | Buy |
224,035
+15,048
| +7% | +$279K | 0.06% | 489 |
|
|
2021
Q2 | $3.81M | Buy |
208,987
+36,815
| +21% | +$859K | 0.04% | 702 |
|
|
2021
Q1 | $3.89M | Buy |
172,172
+82,296
| +92% | +$1.86M | 0.05% | 579 |
|
|
2020
Q4 | $1.8M | Sell |
89,876
-111,676
| -55% | -$2.34M | 0.02% | 1010 |
|
|
2020
Q3 | $4.93M | Sell |
201,552
-188,191
| -48% | -$4.39M | 0.07% | 418 |
|
|
2020
Q2 | $9.25M | Buy |
389,743
+174,720
| +81% | +$4.05M | 0.16% | 115 |
|
|
2020
Q1 | $3.7M | Buy |
215,023
+200,262
| +1,357% | +$3.66M | 0.1% | 251 |
|
|
2019
Q4 | $260K | Buy |
14,761
+11,461
| +347% | +$194K | ﹤0.01% | 1922 |
|
|
2019
Q3 | $58K | Sell |
3,300
-28,488
| -90% | -$577K | ﹤0.01% | 2021 |
|
|
2019
Q2 | $679K | Sell |
31,788
-76,393
| -71% | -$1.6M | 0.01% | 1285 |
|
|
2019
Q1 | $2.58M | Buy |
108,181
+20,704
| +24% | +$472K | 0.08% | 345 |
|
|
2018
Q4 | $1.72M | Buy |
87,477
+70,895
| +428% | +$1.26M | 0.08% | 339 |
|
|
2018
Q3 | $294K | Sell |
16,582
-1,175
| -7% | -$22.9K | 0.02% | 1171 |
|
|
2018
Q2 | $382K | Sell |
17,757
-9,104
| -34% | -$188K | 0.02% | 933 |
|
|
2018
Q1 | $595K | Sell |
26,861
-22,093
| -45% | -$611K | 0.03% | 705 |
|
|
2017
Q4 | $1.49M | Sell |
48,954
-8,960
| -15% | -$238K | 0.08% | 328 |
|
|
2017
Q3 | $1.4M | Buy |
57,914
+20,266
| +54% | +$539K | 0.08% | 286 |
|
|
2017
Q2 | $927K | Buy |
37,648
+14,224
| +61% | +$301K | 0.06% | 458 |
|
|
2017
Q1 | $508K | Sell |
23,424
-81,034
| -78% | -$1.65M | 0.04% | 630 |
|
|
2016
Q4 | $1.56M | Buy |
104,458
+47,894
| +85% | +$691K | 0.12% | 220 |
|
|
2016
Q3 | $723K | Buy |
56,564
+30,609
| +118% | +$331K | 0.05% | 549 |
|
|
2016
Q2 | $203K | Buy |
25,955
+7,285
| +39% | +$42K | 0.01% | 1326 |
|
|
2016
Q1 | $75K | Sell |
18,670
-97,941
| -84% | -$415K | ﹤0.01% | 1437 |
|
|
2015
Q4 | $658K | Sell |
116,611
-76,568
| -40% | -$428K | 0.04% | 683 |
|
|
2015
Q3 | $1.08M | Buy |
193,179
+180,579
| +1,433% | +$983K | 0.05% | 538 |
|
|
2015
Q2 | $47K | Sell |
12,600
-5,380
| -30% | -$17.5K | ﹤0.01% | 1710 |
|
|
2015
Q1 | $46K | Buy |
17,980
+5,380
| +43% | +$12.5K | ﹤0.01% | 1767 |
|
|
2014
Q4 | $18K | Hold |
12,600
| – | – | ﹤0.01% | 1822 |
|
|
2014
Q3 | $19K | Sell |
12,600
-4,700
| -27% | -$15.1K | ﹤0.01% | 1682 |
|
|
2014
Q2 | $59K | Buy |
+17,300
| New | +$59.7K | ﹤0.01% | 1397 |
|
Other funds holding EXEL
FCM
Cubist Systematic Strategies's EXEL Position: Q4 2024 in Review
Cubist Systematic Strategies sold out of Exelixis (EXEL) in Q4 2024, closing a stake of 264,642 shares — an estimated $6.87M sold.
Cubist Systematic Strategies first reported a position in EXEL in Q2 2014 and held it in 41 quarters. The position peaked at $22.3M in Q3 2023. 518 funds tracked by Wall St. Rank hold EXEL as of Q4 2024.
- Cubist Systematic Strategies reported no remaining Exelixis position as of Q4 2024 after selling out during the quarter.
- Cubist Systematic Strategies sold 264,642 Exelixis shares in Q4 2024, an estimated $6.87M.
- Cubist Systematic Strategies first reported a position in Exelixis in Q2 2014 and held it in 41 quarters.
- Cubist Systematic Strategies's Exelixis position peaked at $22.3M in Q3 2023.
- 518 funds tracked by Wall St. Rank held Exelixis as of Q4 2024.
Based on Cubist Systematic Strategies's 13F filing for Q4 2024, filed 14 Feb 2025.